Yifei Ma

429 total citations
33 papers, 277 citations indexed

About

Yifei Ma is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yifei Ma has authored 33 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 12 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Yifei Ma's work include Cancer, Lipids, and Metabolism (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Cancer-related molecular mechanisms research (5 papers). Yifei Ma is often cited by papers focused on Cancer, Lipids, and Metabolism (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Cancer-related molecular mechanisms research (5 papers). Yifei Ma collaborates with scholars based in China and United States. Yifei Ma's co-authors include Xinjun Liang, Ping Lü, Shaozhong Wei, Zili Chen, Chao Yu, Yanyan Liu, Chengyi Sun, Haitao Zhu, Wenhui Li and Shuo Zhang and has published in prestigious journals such as Journal of Clinical Oncology, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Yifei Ma

31 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifei Ma China 11 126 104 87 38 30 33 277
Yutuan Wu China 11 101 0.8× 115 1.1× 133 1.5× 32 0.8× 44 1.5× 26 309
Nicoletta Provinciali Italy 9 83 0.7× 119 1.1× 175 2.0× 54 1.4× 24 0.8× 22 308
Zhangzhou Huang China 8 78 0.6× 71 0.7× 158 1.8× 106 2.8× 27 0.9× 19 279
Camelia Alexandra Coadǎ Italy 10 127 1.0× 103 1.0× 40 0.5× 24 0.6× 11 0.4× 51 293
Jingyu Ma China 9 120 1.0× 59 0.6× 102 1.2× 48 1.3× 47 1.6× 28 265
Yanhui Jiang China 10 277 2.2× 244 2.3× 59 0.7× 33 0.9× 22 0.7× 27 394
Zhixiang Zhuang China 9 106 0.8× 74 0.7× 59 0.7× 34 0.9× 20 0.7× 35 227
Xingsheng Qiu China 10 306 2.4× 256 2.5× 92 1.1× 88 2.3× 21 0.7× 21 456
Daisuke Shintani Japan 10 84 0.7× 76 0.7× 82 0.9× 50 1.3× 37 1.2× 34 293
Boer Shan China 12 81 0.6× 84 0.8× 105 1.2× 48 1.3× 32 1.1× 36 358

Countries citing papers authored by Yifei Ma

Since Specialization
Citations

This map shows the geographic impact of Yifei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifei Ma more than expected).

Fields of papers citing papers by Yifei Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifei Ma. The network helps show where Yifei Ma may publish in the future.

Co-authorship network of co-authors of Yifei Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yifei Ma. A scholar is included among the top collaborators of Yifei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifei Ma. Yifei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuanyuan, Han Qiu, Qiwen Sun, et al.. (2025). Discovery of highly potent mTOR inhibitors aimed at suppressing the progression of acute myeloid leukemia. Bioorganic Chemistry. 157. 108287–108287. 1 indexed citations
2.
Ma, Yifei, et al.. (2025). Why Chinese farmers are reluctant to transfer their land in the context of non-agricultural employment: insights from agricultural mechanization. Humanities and Social Sciences Communications. 12(1). 3 indexed citations
3.
Zhang, Hao, et al.. (2025). Subtype-specific causal effects of hypothyroidism on obstructive sleep apnea: A bidirectional Mendelian randomization study. Medicine. 104(27). e43266–e43266. 1 indexed citations
4.
Ma, Yifei, et al.. (2024). The role of artificial intelligence in the development of anticancer therapeutics from natural polyphenols: Current advances and future prospects. Pharmacological Research. 208. 107381–107381. 5 indexed citations
5.
Wu, Zhimin, et al.. (2024). Mitochondrial-related drug resistance lncRNAs as prognostic biomarkers in laryngeal squamous cell carcinoma. Discover Oncology. 15(1). 785–785. 9 indexed citations
6.
7.
Ma, Yifei, et al.. (2024). The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1. Experimental Cell Research. 438(1). 114006–114006. 4 indexed citations
8.
Zhang, Nana, Yujie Wang, Siyu He, et al.. (2023). Virtual screening of novel mTOR inhibitors for the potential treatment of human colorectal cancer. Bioorganic Chemistry. 140. 106781–106781. 6 indexed citations
9.
Huang, Sha, et al.. (2023). Scoparone induces autophagic cell death via the PAK1/AKT axis in colorectal cancer. European Journal of Pharmacology. 959. 176091–176091. 4 indexed citations
10.
Lü, Ping, Yifei Ma, Jun Wang, et al.. (2022). A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non–Small Cell Lung Cancer. Frontiers in Molecular Biosciences. 8. 784667–784667. 10 indexed citations
11.
Ma, Yifei, et al.. (2022). Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit. Annals of Hepatology. 27(2). 100669–100669. 14 indexed citations
12.
Ma, Yifei, Ping Lü, Shuang Yao, et al.. (2021). Creation of a Novel Nomogram Based on the Direct Bilirubin-To-Indirect Bilirubin Ratio and Lactate Dehydrogenase Levels in Resectable Colorectal Cancer. Frontiers in Molecular Biosciences. 8. 751506–751506. 8 indexed citations
13.
Lü, Ping, Yifei Ma, Shaozhong Wei, & Xinjun Liang. (2021). A Low Albumin-to-Globulin Ratio Predicts a Poor Prognosis in Patients With Metastatic Non-small-cell Lung Cancer. Frontiers in Medicine. 8. 621592–621592. 14 indexed citations
14.
Li, Xinying, Shuang Yao, Yifei Ma, et al.. (2021). Inflammation-Immunity-Nutrition Score: A Novel Prognostic Score for Patients with Resectable Colorectal Cancer. Journal of Inflammation Research. Volume 14. 4577–4588. 10 indexed citations
15.
Ma, Yifei, et al.. (2021). Models Based on Dynamic Clinicopathological Indices for Predicting Prognosis During the Perioperative Period for Patients with Colorectal Cancer. Journal of Inflammation Research. Volume 14. 1591–1601. 5 indexed citations
16.
Lü, Ping, Yifei Ma, Shaozhong Wei, & Xinjun Liang. (2021). The dual role of complement in cancers, from destroying tumors to promoting tumor development. Cytokine. 143. 155522–155522. 16 indexed citations
17.
Liang, Xinjun, Shuang Yao, Ping Lü, et al.. (2021). The Prognostic Value of New Index (LANR) Composed of Pre-operative Lymphocytes, Albumin, and Neutrophils in Patients With Resectable Colorectal Cancer. Frontiers in Oncology. 11. 610264–610264. 9 indexed citations
18.
19.
Chen, Zili, Yifei Ma, Yaozhen Pan, et al.. (2018). MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH. Molecular and Cellular Probes. 40. 19–26. 22 indexed citations
20.
Ma, Yifei, Ting Liu, Yuling Tian, et al.. (2017). Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells. Oncology Letters. 14(2). 1512–1518. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yutuan Wu Breakdown of academic impact, for papers by Nicoletta Provinciali Breakdown of academic impact, for papers by Zhangzhou Huang Breakdown of academic impact, for papers by Camelia Alexandra Coadǎ Breakdown of academic impact, for papers by Jingyu Ma Breakdown of academic impact, for papers by Yanhui Jiang Breakdown of academic impact, for papers by Zhixiang Zhuang Breakdown of academic impact, for papers by Xingsheng Qiu Breakdown of academic impact, for papers by Daisuke Shintani Breakdown of academic impact, for papers by Boer Shan
Rankless by CCL
2026